P1.04-31 Efficacy and Tolerance of Immune-Checkpoint Inhibitors in EGFR, ALK/ROS 1 Non-Small-Cell-Lung-Cancer (NSCLC): GFPC 03-2016 IMAD Study

Saved in:
Bibliographic Details
Published inJournal of thoracic oncology Vol. 13; no. 10; pp. S537 - S538
Main Authors Bylicki, O., Guisier, F., Monnet, I., Doubre, H., Gervais, R., Janicot, H., Pérol, M., Fournel, P., Le Treut, J., Lamy, R., Vieillot, S., Le Caer, H., Auliac, J., Chouaid, C.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.10.2018
Online AccessGet full text

Cover

More Information
ISSN:1556-0864
1556-1380
DOI:10.1016/j.jtho.2018.08.746